LDLRAD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.447600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.374600E-01
Normal-vs-Stage2
6.948200E-01
Normal-vs-Stage3
3.133400E-01
Normal-vs-Stage4
4.795400E-01
Stage1-vs-Stage2
9.106600E-01
Stage1-vs-Stage3
2.471800E-02
Stage1-vs-Stage4
3.997000E-01
Stage2-vs-Stage3
2.03629999973032E-07
Stage2-vs-Stage4
5.547600E-01
Stage3-vs-Stage4
4.139200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.423600E-01
Normal-vs-AfricanAmerican
8.488600E-01
Normal-vs-Asian
2.103200E-01
Caucasian-vs-AfricanAmerican
5.127400E-01
Caucasian-vs-Asian
1.811820E-01
AfricanAmerican-vs-Asian
2.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.584800E-01
Normal-vs-Female
6.420800E-01
Male-vs-Female
9.250600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.089600E-01
Normal-vs-Age(41-60Yrs)
9.064000E-01
Normal-vs-Age(61-80Yrs)
4.270400E-01
Normal-vs-Age(81-100Yrs)
5.015800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.579200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.448200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.708600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.323100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.825560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.725600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.445600E-01
Normal-vs-Daily Drinker
4.860600E-01
Normal-vs-Weekly Drinker
3.162400E-01
Normal-vs-Occasional Drinker
7.958200E-01
Normal-vs-Social Drinker
8.938000E-01
Non Drinker-vs-Daily Drinker
9.576000E-01
Non Drinker-vs-Weekly Drinker
7.706200E-01
Non Drinker-vs-Occasional Drinker
4.099200E-01
Non Drinker-vs-Social Drinker
4.858000E-01
Daily Drinker-vs-Weekly Drinker
8.321200E-01
Daily Drinker-vs-Occasional Drinker
4.435400E-01
Daily Drinker-vs-Social Drinker
4.491000E-01
Weekly Drinker-vs-Occasional Drinker
3.478200E-01
Weekly Drinker-vs-Social Drinker
3.891000E-01
Occasional Drinker-vs-Social Drinker
9.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.188800E-01
Normal-vs-Grade 2
7.972600E-01
Normal-vs-Grade 3
7.672400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.155600E-02
Grade 1-vs-Grade 3
8.667900E-02
Grade 1-vs-Grade 4
8.188800E-01
Grade 2-vs-Grade 3
9.749800E-01
Grade 2-vs-Grade 4
7.972600E-01
Grade 3-vs-Grade 4
7.672400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.124800E-01
Normal-vs-NonDiabetic
5.847800E-01
Diabetic-vs-NonDiabetic
9.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.189360E-01
Normal-vs-NoPancreatitis
6.650000E-01
Pancreatitis-vs-NoPancreatitis
2.317700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.273400E-01
Normal-vs-N1
7.630200E-01
N0-vs-N1
8.639700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.971200E-01
Normal-vs-TP53-NonMutant
8.073200E-01
TP53-Mutant-vs-TP53-NonMutant
3.727000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
